Syntherica’s Mission:  Syntherica’s mission is to develop advanced products for human health utilizing its proprietary Synthetide™ synthetic antibody technology.

About Syntherica:  Syntherica, located in Durham, North Carolina, has developed a platform technology built around Synthetides™, novel constructs of DNA polymers, which mimic the capabilities of natural antibodies.  Syntherica intends to focus its activities on discovering and developing Synthetide™ therapeutic molecules for selected disease indications.  The Company seeks collaboration partners in other areas of drug discovery, in vitro diagnostics, biomarker discovery and outlicensing initiatives.

Synthetides™, which are formed of annealed DNA polymers of unequal length, mimic both the form and function of natural antibodies.  They are designed to have significant advantages over monoclonal antibodies (mAbs), including a rapid and less expensive development process.  Syntherica has created Synthetides™ that bind to a broad range of targets including diverse cell types and both large and small molecules.